The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
Scientists at the Weizmann Institute in Israel found that stem cells from mice could be made to self-assemble into early embryo-like structures with an intestinal tract, the beginnings of a brain, and a beating heart.